In-stent restenosis after carotid angioplasty-stenting: Incidence and management Elie Y. Chakhtoura, MD, Robert W. Hobson, MD, Jonathan Goldstein, MD, Gregory T. Simonian, MD, Brajesh K. Lal, MD, Paul B. Haser, MD, Michael B. Silva, MD, Frank T. Padberg, MD, Peter J. Pappas, MD, Zafar Jamil, MD Journal of Vascular Surgery Volume 33, Issue 2, Pages 220-226 (February 2001) DOI: 10.1067/mva.2001.111880 Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 1 A, Selective angiography in symptomatic patient presenting with single episode of amaurosis fugax 11 months after prior right CEA, demonstrating focal high-grade restenosis (arrow ). B, Poststent deployment angioplasty resulted in technically satisfactory angiographic results (arrows refer to length of stent). C, In-stent restenosis was defined angiographically in two areas (arrows ) in this patient 6 months after CAS. D, Angioplasties of both areas reduced lesions to < 30% residual stenoses (arrows), which have not recurred during a 14-month follow-up. Journal of Vascular Surgery 2001 33, 220-226DOI: (10.1067/mva.2001.111880) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 2 A, Angiographic demonstration of focal in-stent restenosis developing at upper aspect of WallStent (arrow ) 7 months after CAS. B, Treatment with angioplasty and placement of Palmaz stent produced a technically satisfactory angiographic result (notice that external carotid artery was occluded during a prior operative intervention; stenosis at proximal end of prior CEA site demonstrated no pressure gradient and was not treated). Journal of Vascular Surgery 2001 33, 220-226DOI: (10.1067/mva.2001.111880) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions